X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2582) 2582
Book Review (371) 371
Publication (214) 214
Book Chapter (23) 23
Conference Proceeding (9) 9
Book / eBook (7) 7
Government Document (5) 5
Magazine Article (2) 2
Dissertation (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (2237) 2237
humans (1344) 1344
animals (1262) 1262
toxicology (958) 958
male (949) 949
pharmacology & pharmacy (740) 740
female (609) 609
organophosphate poisoning (572) 572
rats (551) 551
organophosphates (524) 524
organophosphate (488) 488
acetylcholinesterase (379) 379
mice (369) 369
poisoning (354) 354
adult (345) 345
toxicity (344) 344
pesticides (342) 342
analysis (275) 275
middle aged (260) 260
atropine - therapeutic use (250) 250
dose-response relationship, drug (249) 249
organophosphates - therapeutic use (247) 247
insecticides (244) 244
organophosphorus compounds (234) 234
acetylcholinesterase - metabolism (226) 226
cholinesterase inhibitors - toxicity (223) 223
organophosphates - pharmacology (218) 218
exposure (207) 207
soman (207) 207
biochemistry & molecular biology (205) 205
antidotes - therapeutic use (203) 203
oximes (202) 202
inhibition (193) 193
insecticides - toxicity (192) 192
chlorpyrifos (189) 189
enzymes (185) 185
organophosphates - toxicity (183) 183
in-vitro (179) 179
brain (177) 177
nerve agents (171) 171
cholinesterase reactivators - therapeutic use (170) 170
atropine (168) 168
time factors (162) 162
cholinesterase (161) 161
pralidoxime compounds - therapeutic use (161) 161
oxidative stress (157) 157
organophosphates - chemistry (156) 156
rats, wistar (156) 156
neurosciences (151) 151
brain - drug effects (149) 149
article (146) 146
insecticides - poisoning (146) 146
aged (144) 144
adolescent (141) 141
organophosphates - administration & dosage (139) 139
health aspects (137) 137
research (136) 136
oximes - therapeutic use (134) 134
treatment outcome (133) 133
cholinesterase inhibitors - poisoning (129) 129
environmental sciences (128) 128
rats, sprague-dawley (126) 126
organophosphorus compounds - toxicity (124) 124
poisoning - drug therapy (124) 124
abridged index medicus (122) 122
nerve gas (122) 122
phosphates (122) 122
sarin (119) 119
lethal dose 50 (116) 116
pharmacokinetics (116) 116
emergency (114) 114
oximes - pharmacology (109) 109
enzyme inhibitors (108) 108
physiological aspects (105) 105
neurotoxicity (104) 104
organophosphate poisoning - drug therapy (104) 104
carbamates (103) 103
cholinesterase reactivators - pharmacology (103) 103
cholinesterases - blood (103) 103
cholinesterase inhibitors - pharmacology (102) 102
efficacy (102) 102
organophosphate pesticides (102) 102
brain - enzymology (101) 101
chlorpyrifos - toxicity (101) 101
intoxication (100) 100
reactivation (100) 100
hiv infections - drug therapy (99) 99
drug therapy, combination (97) 97
kinetics (97) 97
pralidoxime (96) 96
apoptosis (94) 94
organophosphates - pharmacokinetics (94) 94
young adult (94) 94
cell line, tumor (93) 93
chemical warfare agents - toxicity (93) 93
organophosphates - metabolism (93) 93
therapy (93) 93
guinea pigs (92) 92
pesticide (92) 92
chemical warfare agents - poisoning (91) 91
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2506) 2506
German (27) 27
Chinese (15) 15
French (15) 15
Russian (12) 12
Japanese (9) 9
Spanish (8) 8
Polish (7) 7
Hebrew (3) 3
Bulgarian (2) 2
Bosnian (1) 1
Croatian (1) 1
Dutch (1) 1
Hungarian (1) 1
Italian (1) 1
Korean (1) 1
Norwegian (1) 1
Portuguese (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Lancet, ISSN 0140-6736, 2006, Volume 368, Issue 9534, pp. 476 - 482
Lopinavir-ritonavir is a preferred protease inhibitor co-formulation for initial HIV-1 treatment. Fosamprenavir-ritonavir has shown similar efficacy and safety... 
MEDICINE, GENERAL & INTERNAL | THERAPY | NAIVE PATIENTS | RECOMMENDATIONS | EFAVIRENZ | TENOFOVIR DF | RESISTANCE | AIDS | SOCIETY-USA PANEL | LOPINAVIR/RITONAVIR | NELFINAVIR | Dideoxynucleosides - administration & dosage | Organophosphates - administration & dosage | Lamivudine - administration & dosage | Ritonavir - administration & dosage | HIV-1 - drug effects | Humans | Lopinavir | Pyrimidinones - therapeutic use | Organophosphates - therapeutic use | Carbamates - administration & dosage | HIV Protease Inhibitors - administration & dosage | HIV-1 - genetics | Reverse Transcriptase Inhibitors - administration & dosage | HIV Protease Inhibitors - therapeutic use | Sulfonamides - therapeutic use | Lamivudine - therapeutic use | Ritonavir - therapeutic use | HIV Infections - drug therapy | Dideoxynucleosides - therapeutic use | Pyrimidinones - administration & dosage | Reverse Transcriptase Inhibitors - therapeutic use | Carbamates - therapeutic use | Drug Therapy, Combination | Sulfonamides - administration & dosage | Dosage and administration | Protease inhibitors | Comparative analysis | Drug therapy | HIV infection | Antiviral agents | Research | Drug therapy, Combination | Health aspects | Anti-HIV agents | Antiretroviral drugs | Human immunodeficiency virus--HIV | Samples | Clinical trials | Comparative studies | Clinical medicine | Disease control | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
FEBS Journal, ISSN 1742-464X, 12/2015, Volume 282, Issue 24, pp. 4747 - 4765
Renal cell carcinoma ( RCC ) is resistant to traditional cancer therapies, and metastatic RCC (mRCC) is incurable. The shortcomings in current therapeutic... 
apoptosis | triptolide | renal cell carcinoma | TRAIL | death receptor | HEAT-SHOCK-PROTEIN-70 INHIBITS APOPTOSIS | DENDRITIC CELLS | (TRAIL)-INDUCED APOPTOSIS | BIOCHEMISTRY & MOLECULAR BIOLOGY | ANTI-DR5 ANTIBODY THERAPY | HEAT-SHOCK PROTEINS | TUMOR-NECROSIS-FACTOR | APOPTOSIS-INDUCING LIGAND | IN-VIVO | NF-KAPPA-B | PANCREATIC-CANCER CELLS | Recombinant Proteins - therapeutic use | Neoplasm Transplantation | Antineoplastic Combined Chemotherapy Protocols - chemistry | Apoptosis - drug effects | Receptors, TNF-Related Apoptosis-Inducing Ligand - agonists | Humans | Organophosphates - therapeutic use | Antibodies, Monoclonal - therapeutic use | Antineoplastic Agents - therapeutic use | Kidney Neoplasms - metabolism | Receptors, TNF-Related Apoptosis-Inducing Ligand - metabolism | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Epoxy Compounds - pharmacology | TNF-Related Apoptosis-Inducing Ligand - pharmacology | TNF-Related Apoptosis-Inducing Ligand - agonists | Female | Antineoplastic Agents - pharmacology | Antineoplastic Agents, Phytogenic - therapeutic use | Carcinoma, Renal Cell - drug therapy | Antibodies, Monoclonal - chemistry | Diterpenes - pharmacology | Epoxy Compounds - therapeutic use | Diterpenes - therapeutic use | Phenanthrenes - therapeutic use | Specific Pathogen-Free Organisms | Carcinoma, Renal Cell - pathology | Antibodies, Monoclonal - pharmacology | Recombinant Proteins - chemistry | Recombinant Proteins - pharmacology | Antineoplastic Agents - chemistry | TNF-Related Apoptosis-Inducing Ligand - therapeutic use | Drug Synergism | Organophosphates - pharmacology | Carcinoma, Renal Cell - metabolism | Phenanthrenes - pharmacology | Animals | Tumor Burden - drug effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Survival Analysis | Cell Line, Tumor | Kidney Neoplasms - pathology | Mice | Mice, Inbred BALB C | Prodrugs - therapeutic use | Antineoplastic Agents, Phytogenic - pharmacology | Kidney Neoplasms - drug therapy | Prodrugs - pharmacology | TNF-Related Apoptosis-Inducing Ligand - genetics | Heat shock proteins | Carcinoma, Renal cell | Rodents | Tumors | Apoptosis | Index Medicus
Journal Article
British Journal of Cancer, ISSN 0007-0920, 02/2012, Volume 106, Issue 5, pp. 858 - 866
BACKGROUND: The Ras/RAF/MEK/ERK pathway is frequently deregulated in cancer and a number of inhibitors that target this pathway are currently in clinical... 
temozolomide | scheduling | apoptosis | Selumetinib | barasertib | docetaxel | PROTEIN | PHOSPHORYLATION | MAP KINASE | G/M TRANSITION | MULTIPLE-MYELOMA CELLS | SPINDLE-CHECKPOINT | IN-VITRO | ONCOLOGY | MELANOMA-CELLS | KINASE KINASE INHIBITION | PHASE-I | Taxoids - pharmacology | Apoptosis - drug effects | Dacarbazine - therapeutic use | Humans | Organophosphates - therapeutic use | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Neoplasms, Experimental - pathology | Taxoids - therapeutic use | Benzimidazoles - administration & dosage | Dacarbazine - pharmacology | Dacarbazine - analogs & derivatives | Female | Quinazolines - administration & dosage | Antineoplastic Agents - pharmacology | Benzimidazoles - therapeutic use | Organophosphates - administration & dosage | MAP Kinase Kinase 1 - antagonists & inhibitors | Dacarbazine - administration & dosage | Mitogen-Activated Protein Kinase Kinases - antagonists & inhibitors | Organophosphates - pharmacology | Xenograft Model Antitumor Assays | Taxoids - administration & dosage | Animals | MAP Kinase Signaling System - drug effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | MAP Kinase Kinase 2 - antagonists & inhibitors | Mice, Nude | Quinazolines - therapeutic use | Cell Line, Tumor | Benzimidazoles - pharmacology | Cell Proliferation - drug effects | Mice | Protein Kinase Inhibitors - pharmacology | Quinazolines - pharmacology | Neoplasms, Experimental - drug therapy | Index Medicus | Translational Therapeutics
Journal Article
Science Translational Medicine, ISSN 1946-6234, 02/2016, Volume 8, Issue 325, pp. 325ra17 - 325ra17
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 07/2011, Volume 55, Issue 7, pp. 3453 - 3460
Journal Article
JAMA Internal Medicine, ISSN 2168-6106, 01/2016, Volume 176, Issue 1, pp. 75 - 84
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 01/2018, Volume 62, Issue 1
Journal Article
Cancer, ISSN 0008-543X, 07/2013, Volume 119, Issue 14, pp. 2611 - 2619
Journal Article
JAIDS Journal of Acquired Immune Deficiency Syndromes, ISSN 1525-4135, 08/2013, Volume 63, Issue 4, pp. 449 - 455
Journal Article